Get started
GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

GSK chart


Full chart

Key stats


Market capitalization
‪117.71 T‬ ARS
Dividend yield (indicated)
3.84%
Price to earnings Ratio (TTM)
25
Basic EPS (TTM)
600 ARS
Net income (FY)
‪3.01 T‬ ARS
Revenue (FY)
‪36.71 T‬ ARS
Shares float
—
Beta (1Y)
−0.12

About GSK plc


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Emma N. Walmsley
Website
gsk.com
Headquarters
London
ISIN
ARDEUT110483
FIGI
BBG000CZGKJ6
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Check out other big names from the same industry as GSK.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GSK news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

GSK highest yielding bonds


GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
Yield to maturity
—
Maturity date
May 15, 2038
GSK6023691
GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
Yield to maturity
—
Maturity date
Mar 12, 2027
GSK6023692
GlaxoSmithKline Capital Plc FRN 12-MAR-2027
Yield to maturity
—
Maturity date
Mar 12, 2027
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
Yield to maturity
—
Maturity date
Mar 18, 2043
GSK6023693
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
Yield to maturity
—
Maturity date
Apr 15, 2035
GSK6023695
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
Yield to maturity
—
Maturity date
Apr 15, 2030
XS182282812
GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026
Yield to maturity
—
Maturity date
May 21, 2026
XS293369275
GSK Capital BV 3.25% 19-NOV-2036
Yield to maturity
—
Maturity date
Nov 19, 2036
XS168152035
GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029
Yield to maturity
—
Maturity date
Sep 12, 2029
XS293369143
GSK Capital BV 2.875% 19-NOV-2031
Yield to maturity
—
Maturity date
Nov 19, 2031
XS217060907
GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035
Yield to maturity
—
Maturity date
May 12, 2035

See all GSK bonds 

Sparks


Curated watchlists where GSK is featured.

See all sparks